Biofrontera AG (B8FKn)

Currency in EUR
2.610
+0.330(+14.47%)
Closed·
B8FKn Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
B8FKn is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.3602.610
52 wk Range
2.0103.185
Key Statistics
Bid/Ask
2.51 / 2.71
Prev. Close
2.28
Open
2.36
Day's Range
2.36-2.61
52 wk Range
2.01-3.185
Volume
47
Average Volume (3m)
375
1-Year Change
1.11%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
B8FKn Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Biofrontera AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Biofrontera AG Company Profile

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally. The company offers Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. It also provides RhodoLED XL lamp for the treatment of multiple interspersed lesions; and Belixos, a cosmetic product for irritated and sensitive skin. The company has a license and supply agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

Employees
87
Market
Germany

Compare B8FKn to Peers and Sector

Metrics to compare
B8FKn
Peers
Sector
Relationship
P/E Ratio
−15.9x14.9x−0.5x
PEG Ratio
0.050.350.00
Price/Book
0.8x1.2x2.6x
Price / LTM Sales
0.6x2.3x3.2x
Upside (Analyst Target)
-31.7%41.2%
Fair Value Upside
Unlock19.9%6.2%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
0.11 / --
Revenue / Forecast
5.77M / --
EPS Revisions
Last 90 days

B8FKn Income Statement

FAQ

What Stock Exchange Does Biofrontera AG Trade On?

Biofrontera AG is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Biofrontera AG?

The stock symbol for Biofrontera AG is "B8FKn."

What Is the Biofrontera AG Market Cap?

As of today, Biofrontera AG market cap is 15.86M.

What Is Biofrontera AG's Earnings Per Share (TTM)?

The Biofrontera AG EPS (TTM) is -0.13.

When Is the Next Biofrontera AG Earnings Date?

Biofrontera AG will release its next earnings report on 27 Aug 2025.

From a Technical Analysis Perspective, Is B8FKn a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Biofrontera AG Stock Split?

Biofrontera AG has split 6 times.

How Many Employees Does Biofrontera AG Have?

Biofrontera AG has 87 employees.

What is the current trading status of Biofrontera AG (B8FKn)?

As of 29 Jul 2025, Biofrontera AG (B8FKn) is trading at a price of 2.61, with a previous close of 2.28. The stock has fluctuated within a day range of 2.36 to 2.61, while its 52-week range spans from 2.01 to 3.19.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.